Skip to Main Navigation
Skip to Page Content

COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/10499

Promethazine hydrochloride: Target Organs and Levels of Evidence for TR-425

Toxicology and Carcinogenesis Studies of Promethazine Hydrochloride (CASRN 58-33-3) in F344/N Rats and B6C3F1 Mice (Gavage Studies)

Chemical (Study Title)
CASRN
Peer Review Date Route/Exposure Levels Study Laboratory
Promethazine hydrochloride
58-33-3
Gavage
R: 0,3.7,300, M: 0,5,405 MG/10 PER GROUP
Litton Bionetics, Inc.

Levels of Evidence: None



Chemical (Study Title)
CASRN
Peer Review Date Route/Exposure Levels Study Laboratory
Promethazine hydrochloride
58-33-3
12/01/1992 Gavage
R: 0,8.3,16.6,33.3, FM: 0,3.75,7.5,15.0, MM: 0,11.25,22.5,45.0 MG/KG
T.S.I. Mason Laboratories, Inc.

Levels of Evidence

Male Rats: No Evidence
Type Organ/Tissue (Lesion)
Non-Neoplastic Lesions
  • LIVER: DIFFUSE FATTY CHANGE
Other Considerations
  • ADRENAL GLAND: PHEOCHROMOCYTOMA 14/50 11/50 8/50 2/51 OR MALIGNANT PHEOCHROMOCYTOMA 3/50 1/50 1/50 1/51 COMBINED 16/50 12/50 9/49 4/50
  • PITUITARY GLAND: ADENOMA 16/50 16/50 16/48 8/50
Female Rats: No Evidence
Type Organ/Tissue (Lesion)
Other Considerations
  • UTERUS/CERVIX: STROMAL POLYP 10/50 6/50 4/50 1/53
Male Mice: No Evidence
Female Mice: No Evidence